Dr. Wilcox is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1303 N Main St
Cedar City, UT 84721Phone+1 435-868-5690Fax+1 435-688-4901
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2012 - 2016
- University of Utah HealthResidency, Internal Medicine, 2009 - 2012
- University of Utah School of MedicineClass of 2009
Certifications & Licensure
- AZ State Medical License 2021 - Present
- UT State Medical License 2010 - 2026
- NV State Medical License 2021 - 2025
- CO State Medical License 2021 - 2023
- ID State Medical License 2018 - 2023
- WY State Medical License 2018 - 2023
- MN State Medical License 2012 - 2016
Publications & Presentations
PubMed
- 2 citationsRegorafenib in Patients With Solid Tumors WithAlterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.Vaibhav Sahai, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vijay Suhag
JCO Precision Oncology. 2024-04-01 - 4 citationsHospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice.Ryan Wilcox, Robert C. Pendleton, Kristi J. Smock, George M. Rodgers
Hospital Practice. 2011-08-01 - 37 citationsA pharmacogenomic method for individualized prediction of drug sensitivityAdam L. Cohen, Raffaella Soldi, Haiyu Zhang, Adam M. Gustafson, Ryan Wilcox
Molecular Systems Biology. 2011-01-01
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: